New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to severely active ...
As Greg Ward prepares to take over as CEO, the group’s evolution has seen it restructure its principal investment unit and ...
A long-winded introduction Well, it has been a while since my last update. I would like to conduct stock analysis on Japanese ...
Continued global apparel breakthrough, analysis of Fast Retailing's fiscal year ending August 2026Fast Retailing's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results